DOI: 10.4103/ijra.ijra_28_26 ISSN: 3117-4051

Comparative Outcomes of Antimiasmatic Treatment and Rauwolfia serpentina in Primary Hypertension: An Observational Pilot Study

Shrinidhi Srinivas Kulkarni, Skandhan S. Kumar
Show PDF Cite

Abstract

Background:

Primary hypertension (HTN), an elevated blood pressure (BP) of unknown cause, and secondary HTN, caused by various diseases, both lead to cardiovascular complications. In 1949, Vakil’s study of 50 patients with essential HTN treated with Rauwolfia showed 85% had a drop in systolic BP (SBP) and 81% in diastolic BP (DBP). Similarly, Vida reported BP reduction in 25 HTN patients in 1952.

Objective:

The objective of this study was to compare outcomes of antimiasmatic remedies and Rauwolfia serpentina in reducing SBP and DBP in primary HTN patients and to explore the correlation between miasmatic classification and BP reduction.

Methods:

An observational comparative pilot study was conducted with 64 HTN patients, divided into two groups: antimiasmatic remedies ( n = 32) and R. serpentina ( n = 32). Patients were classified into miasms based on their symptomatology. BP readings were recorded over a 6-month period. Statistical analysis was performed using the Mann–Whitney U -test to assess the significance of BP reductions.

Results:

The antimiasmatic group showed a statistically significant reduction in SBP ( P < 0.05) compared to the R. serpentina group. No significant difference was observed in DBP reduction between the two groups. Notably, patients with a psoric miasm exhibited greater reductions in SBP, while those with a sycotic miasm showed more pronounced reductions in DBP.

Conclusion:

Antimiasmatic treatment was associated with a greater observed reduction in SBP among patients with primary HTN. The observed findings should be interpreted cautiously, given the observational design and potential confounding factors. The observed correlations between miasmatic classifications and specific BP reductions warrant further investigation through larger, randomized controlled trials to validate these findings and enhance the evidence base for homeopathic management of HTN.

More from our Archive